Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Paolella BR"'
Autor:
Krill-Burger JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Dempster JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Borah AA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Paolella BR; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Root DE; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Golub TR; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Boehm JS; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Hahn WC; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., McFarland JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Vazquez F; Broad Institute of Harvard and MIT, Cambridge, MA, USA. vazquez@broadinstitute.org.; Dana-Farber Cancer Institute, Boston, MA, USA. vazquez@broadinstitute.org., Tsherniak A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Publikováno v:
Genome biology [Genome Biol] 2023 Aug 23; Vol. 24 (1), pp. 192. Date of Electronic Publication: 2023 Aug 23.
Autor:
Bondeson DP; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mullin-Bernstein Z; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Oliver S; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Skipper TA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Atack TC; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bick N; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ching M; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Guirguis AA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Kwon J; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Langan C; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Millson D; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Paolella BR; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tran K; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Wie SJ; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Vazquez F; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tothova Z; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Golub TR; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Sellers WR; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ianari A; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. aleianari12@gmail.com.
Publikováno v:
Nature communications [Nat Commun] 2022 Sep 20; Vol. 13 (1), pp. 5495. Date of Electronic Publication: 2022 Sep 20.
Autor:
Bondeson DP; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Paolella BR; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Merck Research Laboratories, Cambridge, MA, USA., Asfaw A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rothberg MV; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Skipper TA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Langan C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mesa G; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gonzalez A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Surface LE; Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ito K; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kazachkova M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Colgan WN; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Warren A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dempster JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Krill-Burger JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ericsson M; Harvard Medical School, Boston, MA, USA., Tang AA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Fung I; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Chambers ES; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Abdusamad M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dumont N; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Piccioni F; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Merck Research Laboratories, Cambridge, MA, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Boehm J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hahn WC; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Departments of Pediatric and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Mannstadt M; Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., McFarland JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Vazquez F; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA, USA. golub@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. golub@broadinstitute.org.; Departments of Pediatric and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. golub@broadinstitute.org.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Jun; Vol. 3 (6), pp. 681-695. Date of Electronic Publication: 2022 Apr 18.
Autor:
Ito T; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Scorpion Therapeutics, Boston, MA, USA., Young MJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Li R; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Jain S; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Wernitznig A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Krill-Burger JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Lemke CT; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Monducci D; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Rodriguez DJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Chang L; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Dutta S; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Pal D; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Paolella BR; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Rothberg MV; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Root DE; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Johannessen CM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Oncology, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Parida L; IBM Research, T.J. Watson Research Center, Yorktown Heights, NY, USA., Getz G; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Vazquez F; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Doench JG; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Zamanighomi M; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Sellers WR; Broad Institute of Harvard and MIT, Cambridge, MA, USA. wsellers@broadinstitute.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wsellers@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. wsellers@broadinstitute.org.
Publikováno v:
Nature genetics [Nat Genet] 2021 Dec; Vol. 53 (12), pp. 1664-1672. Date of Electronic Publication: 2021 Dec 02.
Autor:
Malone CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Kugener G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Forman AB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rothberg MV; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Abdusamad M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Gonzalez A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Kuljanin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dempster JM; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Paolella BR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Dumont N; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Hovestadt V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Younger ST; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Root DE; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Golub TR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Vazquez F; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Kimberly_stegmaier@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Sep; Vol. 11 (9), pp. 2282-2299. Date of Electronic Publication: 2021 Apr 21.
Autor:
Neggers JE, Paolella BR, Asfaw A, Rothberg MV, Skipper TA, Yang A, Kalekar RL, Krill-Burger JM, Dharia NV, Kugener G, Kalfon J, Yuan C, Dumont N, Gonzalez A, Abdusamad M, Li YY, Spurr LF, Wu WW, Durbin AD, Wolpin BM, Piccioni F, Root DE, Boehm JS, Cherniack AD, Tsherniak A, Hong AL, Hahn WC, Stegmaier K, Golub TR, Vazquez F, Aguirre AJ
Publikováno v:
Cell reports [Cell Rep] 2021 Jul 13; Vol. 36 (2), pp. 109367.
Autor:
Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Kugener G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA., Guenther LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Malone CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Durbin AD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Oncology, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, TN, USA., Hong AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pediatrics, Emory University and Department of Hematology and Oncology, Children's Healthcare of Atlanta, Atlanta, GA, USA., Howard TP; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Wechsler CS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Fung I; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Warren AC; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dempster JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Krill-Burger JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Paolella BR; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Moh P; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; University of Maryland, College Park, MD, USA., Jha N; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tang A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Montgomery P; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Boehm JS; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hahn WC; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Roberts CWM; Department of Oncology, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, TN, USA., McFarland JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tsherniak A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Golub TR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Vazquez F; Broad Institute of MIT and Harvard, Cambridge, MA, USA. vazquez@broadinstitute.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. vazquez@broadinstitute.org., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. kimberly_stegmaier@dfci.harvard.edu.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. kimberly_stegmaier@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. kimberly_stegmaier@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. kimberly_stegmaier@dfci.harvard.edu.
Publikováno v:
Nature genetics [Nat Genet] 2021 Apr; Vol. 53 (4), pp. 529-538. Date of Electronic Publication: 2021 Mar 22.
Autor:
Neggers JE; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Paolella BR; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Asfaw A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Rothberg MV; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Skipper TA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Kalekar RL; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Krill-Burger JM; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Dharia NV; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Cancer and Blood Disorders Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Kugener G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Kalfon J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Dumont N; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Gonzalez A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Abdusamad M; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Li YY; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Spurr LF; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Wu WW; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Durbin AD; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Cancer and Blood Disorders Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Piccioni F; Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Root DE; Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Boehm JS; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Cherniack AD; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Tsherniak A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Hong AL; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Cancer and Blood Disorders Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Hahn WC; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Stegmaier K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Cancer and Blood Disorders Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Golub TR; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Vazquez F; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Electronic address: vazquez@broadinstitute.org., Aguirre AJ; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Electronic address: andrew_aguirre@dfci.harvard.edu.
Publikováno v:
Cell reports [Cell Rep] 2020 Dec 15; Vol. 33 (11), pp. 108493.
Autor:
McFarland JM; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Paolella BR; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Warren A; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Geiger-Schuller K; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Shibue T; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Rothberg M; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Kuksenko O; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Colgan WN; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Jones A; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Chambers E; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Dionne D; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Bender S; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Wolpin BM; Harvard Medical School, Boston, 02115, MA, USA.; Brigham and Women's Hospital, Boston, 02115, MA, USA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, 02115, MA, USA., Ghandi M; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Tirosh I; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Rozenblatt-Rosen O; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Roth JA; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Harvard Medical School, Boston, 02115, MA, USA.; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, 02115, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, 20815, MD, USA., Regev A; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, 20815, MD, USA.; Koch Institute of Integrative Cancer Research, Cambridge, 021242, MA, USA.; Department of Biology, MIT, Cambridge, 021242, MA, USA., Aguirre AJ; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA. andrew_aguirre@dfci.harvard.edu.; Harvard Medical School, Boston, 02115, MA, USA. andrew_aguirre@dfci.harvard.edu.; Brigham and Women's Hospital, Boston, 02115, MA, USA. andrew_aguirre@dfci.harvard.edu.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, 02115, MA, USA. andrew_aguirre@dfci.harvard.edu., Vazquez F; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA. vazquez@broadinstitute.org., Tsherniak A; Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA. aviad@broadinstitute.org.
Publikováno v:
Nature communications [Nat Commun] 2020 Aug 27; Vol. 11 (1), pp. 4296. Date of Electronic Publication: 2020 Aug 27.
Autor:
Lu Z; Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Paolella BR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02139, United States., Truex NL; Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Loftis AR; Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Liao X; Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Rabideau AE; Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Brown MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02139, United States., Busanovich J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02139, United States., Beroukhim R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02139, United States., Pentelute BL; Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2020 Jun 19; Vol. 15 (6), pp. 1358-1369. Date of Electronic Publication: 2020 May 11.